Brain & Life
October 07, 2024
In a story about the possibility of new weight loss drugs reducing the risk of neurologic disorders, Brain & Life magazine reports that neurologists have long seen an association between weight loss and improvement of symptoms in multiple sclerosis. Dennis Bourdette, M.D., says, “Our MS center has a handful of patients taking GLP-1 receptor agonists. We often see a reduction in symptoms and an improvement in daily functioning among those who have had a fairly dramatic weight loss through dieting, exercise and sometimes bariatric surgery. Losing weight improves energy, strength, and balance and helps prevent injury to joints caused by obesity.”